Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

41.53
-0.2349-0.56%
Post-market: 41.47-0.0585-0.14%19:30 EDT
Volume:28.72K
Turnover:1.20M
Market Cap:203.90M
PE:- -
High:42.30
Open:42.30
Low:41.47
Close:41.76
52wk High:47.00
52wk Low:26.62
Shares:4.91M
Float Shares:4.91M
Volume Ratio:1.14
T/O Rate:0.58%
Dividend:0.02
Dividend Rate:0.05%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
49 mins ago

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
16 hours ago

Eli Lilly Stock (LLY) in Focus as Company Completes $3.8 Billion AtaiBeckley Purchase

TIPRANKS
·
Yesterday

Eli Lilly Completes Acquisition of AtaiBeckley

Reuters
·
Yesterday

Lilly Completes Acquisition of Ataibeckley to Advance Therapies for Treatment-Resistant Depression and Other Mental Health Conditions

THOMSON REUTERS
·
Yesterday

Legend Biotech : Barclays Cuts Target Price to $74 from $78

THOMSON REUTERS
·
Yesterday

MS Cuts Novo Nordisk on Growth Prospects, Patent Expiry Risks

Reuters
·
Yesterday

Growth Without AI: 8 Stock Picks

Dow Jones
·
Yesterday

Revolution Medicines Director Lorence H. Kim Disposes of 17,090 Common Shares Worth USD 3.57 Million

Reuters
·
Yesterday

Insight Guru Flags Valuation Flip as Merck Trades at 52.2x Operating Profit vs Lilly 25.3x

Reuters
·
Yesterday

Revolution Medicines Got a 'Miracle' Cancer Drug Approval. Wall Street Wants More.

Dow Jones
·
Yesterday

Revolution Medicines to Gain From Drug Expansion, New Combination Therapies, Morgan Stanley Says

MT Newswires Live
·
Sep 10

Eli Lilly is Maintained at Reduce by HSBC

Dow Jones
·
Sep 10

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

Reuters
·
Sep 10

GenScript Unit Legend Biotech to Present Updated Long-Term Carvykti Cartitude-2 Data at IMS Meeting

Reuters
·
Sep 10

Revolution Medicines, Inc. : Morgan Stanley Initiates Coverage with Overweight Rating; Price Target $255

THOMSON REUTERS
·
Sep 10

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live
·
Sep 10

BeOne Medicines FY26 H1 Net Income Climbs to Us$464.36 Million; Revenue Rises 32.3% to Us$3.22 Billion

Reuters
·
Sep 10

Roche's Drug Pipeline is Deeper than Market Assumes

Dow Jones
·
Sep 09

Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL), Revolution Medicines (RVMD) and Intellia Therapeutics (NTLA)

TIPRANKS
·
Sep 09